Inventor · disambiguated record
Sarah Spiegel
Also filed as: SPIEGEL SARAH
18 granted patents·1 pending application·147 citations·filing 1991–2021
94Inventor score
Top patents by PatentIndex Score
19 records- 0196US9388121B2Sphingosine kinase type 1 inhibitorsENZO THERAPEUTICS INC·Filed 2012·Granted Jul 12, 2016·16 cites·12 claims
- 0295US10456370B2Sphingosine kinase type 1 inhibitors and uses thereofENZO THERAPEUTICS INC·Filed 2018·Granted Oct 29, 2019·4 cites·9 claims
- 0395US10166204B2Sphingosine kinase type 1 inhibitors and uses thereofENZO THERAPEUTICS INC·Filed 2018·Granted Jan 1, 2019·4 cites·18 claims
- 0495US9974758B2Sphingosine kinase type 1 inhibitors and uses thereofENZO THERAPEUTICS INC·Filed 2016·Granted May 22, 2018·6 cites·12 claims
- 0593US8372888B2Sphingosine kinase type 1 inhibitors, compositions and processes for using sameENZO THERAPEUTICS INC·Filed 2009·Granted Feb 12, 2013·30 cites·5 claims
- 0692US8314151B2Sphingosine kinase type 1 inhibitors, and processes for using sameSPIEGEL SARAH·Filed 2009·Granted Nov 20, 2012·21 cites·6 claims
- 0777US11737992B2Sphingosine kinase Type 1 inhibitors and uses thereofENZO THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·0 cites·10 claims
- 0873US10945971B2Sphingosine kinase type 1 inhibitors and uses thereofENZO THERAPEUTICS INC·Filed 2020·Granted Mar 16, 2021·0 cites·20 claims
- 0973US10624863B2Sphingosine kinase type 1 inhibitors and uses thereofENZO THERAPEUTICS INC·Filed 2019·Granted Apr 21, 2020·0 cites·10 claims
- 1070US6800470B2Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereofSANKYO CO·Filed 2001·Granted Oct 5, 2004·3 cites·18 claims
- 1170US5712262AUse of sphingosine-1-phosphate to suppress programmed cell deathFiled 1996·Granted Jan 27, 1998·33 cites·5 claims
- 1263US7803595B2Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereofSANKYO CO·Filed 2007·Granted Sep 28, 2010·0 cites·15 claims
- 1357US7419814B2Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereofSANKYO CO·Filed 2004·Granted Sep 2, 2008·0 cites·3 claims
- 1457US5374616ACompositions containing sphingosylphosphorylcholine and the use thereof as a cellular growth factorUNIV GEORGETOWN·Filed 1991·Granted Dec 20, 1994·27 cites·3 claims
- 1556US9598384B23-(2-amino-ethyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-alkylidene-1,3-dihydro-indol-2-one derivatives as selective sphingosine kinase 2 inhibitorsUNIV VIRGINIA COMMONWEALTH·Filed 2015·Granted Mar 21, 2017·0 cites·12 claims
- 1653US8263349B2Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereofSPIEGEL SARAH·Filed 2010·Granted Sep 11, 2012·0 cites·12 claims
- 1750US2015005353A13-(2-amino-ethyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-alkylidene-1,3-dihydro-indol-2-one derivatives as selective sphingosine kinase 2 inhibitorsUNIV VIRGINIA COMMONWEALTH·Filed 2013·Application pending·0 cites
- 1845US6830916B2Sphingosine kinase, cloning, expression and methods of useFiled 2001·Granted Dec 14, 2004·0 cites·4 claims
- 1936US5714478ASphingosylphosphorylcholine as a wound-healing agentFiled 1996·Granted Feb 3, 1998·3 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Sarah Spiegel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →